Old Web
English
Sign In
Acemap
>
authorDetail
>
S. Krycz-Krzemien
S. Krycz-Krzemien
Immunology
Nuclear medicine
Toxicity
Survival rate
Radioimmunotherapy
2
Papers
20
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
90Y-Zevalin® (90Y-Ibritumomab Tiuxetan) Radioimmunotherapy (RIT) Consolidation of FCM Induction Chemotherapy in Mantle Cell Lymphoma (MCL) Patients: Results from the PLRG upon Completed Enrollment.
2006
Blood
Wojciech Jurczak
Agnieszka Giza
Marta Szostek
Alicja Hubalewska-Dydejczyk
Anna Sowa-Staszczak
Wanda Knopinska-Posluszny
Andrzej Hellmann
Barbara Zdziarska
Tomasz Wróbel
S. Krycz-Krzemien
Lidia Poplawska
Irena Federowicz
Jan Walewski
Aleksander B. Skotnicki
Show All
Source
Cite
Save
Citations (15)
Consolidation of Chemotherapy Response in Mantle Cell Lymphoma (MCL) Patients with 90Y-Ibritumomab Tiuxetan (90Y-Zevalin) Radioimmunotherapy (RIT).
2005
Blood
Wojciech Jurczak
Agnieszka Giza
Dorota Krochmalczyk
Joanna Wegrzyn
Alicja Hubalewska-Dydejczyk
Anna Sowa-Staszczak
Wanda Knopinska-Posluszny
Barbara Zdziarska
S. Krycz-Krzemien
Piotr Boguradzki
Lidia Poplawska
Aleksander B. Skotnicki
Show All
Source
Cite
Save
Citations (5)
1